BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37802757)

  • 1. Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates.
    Saleh JS; Subtil A; Hristov AC
    Hum Pathol; 2023 Oct; 140():75-100. PubMed ID: 37802757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates.
    Saleh JS; Subtil A; Hristov AC
    Hum Pathol; 2023 Aug; 138():76-102. PubMed ID: 37307932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Cutaneous Lymphomas in Children and Adolescents.
    Ceppi F; Pope E; Ngan B; Abla O
    Pediatr Blood Cancer; 2016 Nov; 63(11):1886-94. PubMed ID: 27229270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.
    Wada DA; Law ME; Hsi ED; Dicaudo DJ; Ma L; Lim MS; Souza Ad; Comfere NI; Weenig RH; Macon WR; Erickson LA; Ozsan N; Ansell SM; Dogan A; Feldman AL
    Mod Pathol; 2011 Apr; 24(4):596-605. PubMed ID: 21169992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous CD30(+) lymphoproliferative disorders.
    Wieser I; Tetzlaff MT; Torres Cabala CA; Duvic M
    J Dtsch Dermatol Ges; 2016 Aug; 14(8):767-82. PubMed ID: 27509411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis.
    Stoll JR; Willner J; Oh Y; Pulitzer M; Moskowitz A; Horwitz S; Myskowski P; Noor SJ
    J Am Acad Dermatol; 2021 Nov; 85(5):1073-1090. PubMed ID: 33940098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical Management of CD30⁺ Lymphoproliferative Disorders.
    Hughey LC
    Dermatol Clin; 2015 Oct; 33(4):819-33. PubMed ID: 26433852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Cutaneous CD30+ Lymphoproliferative Disorders: a Comprehensive Review.
    Di Raimondo C; Parekh V; Song JY; Rosen ST; Querfeld C; Zain J; Martinez XU; Abdulla FR
    Curr Hematol Malig Rep; 2020 Aug; 15(4):333-342. PubMed ID: 32435988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cutaneous lymphomas: new entities and rare variants].
    Kempf W; Mitteldorf C
    Pathologe; 2015 Feb; 36(1):62-9. PubMed ID: 25589355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous CD30+ lymphoproliferative disorders: new insights into biology and therapy.
    Querfeld C; Kuzel TM; Guitart J; Rosen ST
    Oncology (Williston Park); 2007 May; 21(6):689-96; discussion 699-700,. PubMed ID: 17564326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous Lymphomas - Part I: Mycosis Fungoides, Sézary Syndrome, and CD30
    Pujol RM; Gallardo F
    Actas Dermosifiliogr (Engl Ed); 2021 Jan; 112(1):14-23. PubMed ID: 32896500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and Management of Cutaneous Lymphomas Including Cutaneous T-cell Lymphoma.
    Zic JA
    Med Clin North Am; 2021 Jul; 105(4):737-755. PubMed ID: 34059248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies and considerations in the diagnosis of primary cutaneous CD4⁺ small/medium T-cell lymphoma.
    Lan TT; Brown NA; Hristov AC
    Arch Pathol Lab Med; 2014 Oct; 138(10):1307-18. PubMed ID: 25268194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous T-cell lymphomas in childhood and adolescence.
    Wohlmuth-Wieser I
    J Dtsch Dermatol Ges; 2021 Apr; 19(4):563-581. PubMed ID: 33861015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary cutaneous lymphoma-a case series of 163 patients].
    Nashan D; Friedrich CM; Geissler E; Schmitt-Graeff A; Klein F; Meiss F
    Hautarzt; 2018 Dec; 69(12):1014-1020. PubMed ID: 29881891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
    Paulli M; Berti E
    Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Practice Guidelines for Cutaneous Lymphomas.
    Sutton AM; Hurley MY
    Mo Med; 2015; 112(4):292-5. PubMed ID: 26455060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD30-Positive Lymphoproliferative Disorders.
    Nikolaenko L; Zain J; Rosen ST; Querfeld C
    Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma.
    Gill RPK; Gantchev J; Martínez Villarreal A; Ramchatesingh B; Netchiporouk E; Akilov OE; Ødum N; Gniadecki R; Koralov SB; Litvinov IV
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.